Gradient Investments’s NanoViricides NNVC Stock Holding History

Gradient Investments’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-49	Closed	–	–	1609
2022 Q3	$0	Buy	+49	New	+$107	﹤0.01%	1475

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Gradient Investments's NNVC Position: Q4 2022 in Review

Gradient Investments sold out of NanoViricides (NNVC) in Q4 2022, closing a stake of 49 shares.

Gradient Investments first reported a position in NNVC in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 30 funds tracked by Wall St. Rank hold NNVC as of Q4 2022.

Gradient Investments reported no remaining NanoViricides position as of Q4 2022 after selling out during the quarter.
Gradient Investments sold 49 NanoViricides shares in Q4 2022.
Gradient Investments first reported a position in NanoViricides in Q3 2022 and held it in 1 quarter.
Gradient Investments's NanoViricides position peaked at $0 in Q3 2022.
30 funds tracked by Wall St. Rank held NanoViricides as of Q4 2022.

Based on Gradient Investments's 13F filing for Q4 2022, filed 10 Jan 2023.